These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21622827)

  • 1. 2',3'-cAMP, 3'-AMP, and 2'-AMP inhibit human aortic and coronary vascular smooth muscle cell proliferation via A2B receptors.
    Jackson EK; Ren J; Gillespie DG
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H391-401. PubMed ID: 21622827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2'-AMP and 3'-AMP inhibit proliferation of preglomerular vascular smooth muscle cells and glomerular mesangial cells via A2B receptors.
    Jackson EK; Gillespie DG; Dubey RK
    J Pharmacol Exp Ther; 2011 May; 337(2):444-50. PubMed ID: 21270135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular 2,3-cyclic adenosine monophosphate is a potent inhibitor of preglomerular vascular smooth muscle cell and mesangial cell growth [corrected].
    Jackson EK; Ren J; Gillespie DG; Dubey RK
    Hypertension; 2010 Jul; 56(1):151-8. PubMed ID: 20516392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Vascular Smooth Muscle Cell Proliferation by ENPP1: The Role of CD73 and the Adenosine Signaling Axis.
    Tchernychev B; Nitschke Y; Chu D; Sullivan C; Flaman L; O'Brien K; Howe J; Cheng Z; Thompson D; Ortiz D; Rutsch F; Sabbagh Y
    Cells; 2024 Jun; 13(13):. PubMed ID: 38994980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A₂B receptors mediate the induction of early genes and inhibition of arterial smooth muscle cell proliferation via Epac.
    Mayer P; Hinze AV; Harst A; von Kügelgen I
    Cardiovasc Res; 2011 Apr; 90(1):148-56. PubMed ID: 21109603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine Attenuates Human Coronary Artery Smooth Muscle Cell Proliferation by Inhibiting Multiple Signaling Pathways That Converge on Cyclin D.
    Dubey RK; Fingerle J; Gillespie DG; Mi Z; Rosselli M; Imthurn B; Jackson EK
    Hypertension; 2015 Dec; 66(6):1207-19. PubMed ID: 26416848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine, Via A
    Dubey RK; Baruscotti I; Stiller R; Fingerle J; Gillespie DG; Mi Z; Leeners B; Imthurn B; Rosselli M; Jackson EK
    Hypertension; 2020 Jan; 75(1):109-118. PubMed ID: 31786976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic AMP-adenosine pathway inhibits vascular smooth muscle cell growth.
    Dubey RK; Mi Z; Gillespie DG; Jackson EK
    Hypertension; 1996 Nov; 28(5):765-71. PubMed ID: 8901821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular 3',5'-cAMP-adenosine pathway inhibits glomerular mesangial cell growth.
    Dubey RK; Rosselli M; Gillespie DG; Mi Z; Jackson EK
    J Pharmacol Exp Ther; 2010 Jun; 333(3):808-15. PubMed ID: 20194527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Egr1 expression underlies the anti-mitogenic effects of cAMP in vascular smooth muscle cells.
    Kimura TE; Duggirala A; Hindmarch CC; Hewer RC; Cui MZ; Newby AC; Bond M
    J Mol Cell Cardiol; 2014 Jul; 72(100):9-19. PubMed ID: 24534707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cAMP-producing agonist beraprost inhibits human vascular smooth muscle cell migration via exchange protein directly activated by cAMP.
    McKean JS; Murray F; Gibson G; Shewan DA; Tucker SJ; Nixon GF
    Cardiovasc Res; 2015 Sep; 107(4):546-55. PubMed ID: 26092100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced levels of cyclic AMP contribute to the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats.
    Saha S; Li Y; Anand-Srivastava MB
    Can J Physiol Pharmacol; 2008 Apr; 86(4):190-8. PubMed ID: 18418428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ecto-5'-nucleotidase, CD73, is an endothelium-derived hyperpolarizing factor synthase.
    Ohta M; Toyama K; Gutterman DD; Campbell WB; Lemaître V; Teraoka R; Miura H
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):629-36. PubMed ID: 23288168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired peroxisome proliferator-activated receptor-gamma contributes to phenotypic modulation of vascular smooth muscle cells during hypertension.
    Zhang L; Xie P; Wang J; Yang Q; Fang C; Zhou S; Li J
    J Biol Chem; 2010 Apr; 285(18):13666-77. PubMed ID: 20212046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nifedipine inhibits vascular smooth muscle cell proliferation and reactive oxygen species production through AMP-activated protein kinase signaling pathway.
    Sung JY; Choi HC
    Vascul Pharmacol; 2012; 56(1-2):1-8. PubMed ID: 21708289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
    Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
    Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular 2',3'-cAMP-adenosine pathway in proximal tubular, thick ascending limb, and collecting duct epithelial cells.
    Jackson EK; Gillespie DG
    Am J Physiol Renal Physiol; 2013 Jan; 304(1):F49-55. PubMed ID: 23077101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of inducible NO synthase by exogenous adenosine in vascular smooth muscle cells activated by inflammatory stimuli in experimental diabetes.
    Nassi A; Malorgio F; Tedesco S; Cignarella A; Gaion RM
    Cardiovasc Diabetol; 2016 Feb; 15():32. PubMed ID: 26879172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenine attenuates the Ca(2+) contraction-signaling pathway via adenine receptor-mediated signaling in rat vascular smooth muscle cells.
    Fukuda T; Kuroda T; Kono M; Hyoguchi M; Tajiri S; Tanaka M; Mine Y; Matsui T
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Sep; 389(9):999-1007. PubMed ID: 27318925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice.
    Bot I; de Vries H; Korporaal SJ; Foks AC; Bot M; van Veldhoven J; Ter Borg MN; van Santbrink PJ; van Berkel TJ; Kuiper J; Ijzerman AP
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2197-205. PubMed ID: 22743060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.